Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma

BACKGROUND: Cholangiocarcinoma (CCA) is one of the most fatal malignant tumors with increasing incidence, mortality, and insensitivity to traditional chemo-radiotherapy and targeted therapy. Chimeric antigen receptor-modified T cell (CART) immunotherapy represents a novel strategy for the management...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Kai-chao, Guo, Ye-lei, Liu, Yang, Dai, Han-ren, Wang, Yao, Lv, Hai-yan, Huang, Jian-hua, Yang, Qing-ming, Han, Wei-dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217546/
https://www.ncbi.nlm.nih.gov/pubmed/28057014
http://dx.doi.org/10.1186/s13045-016-0378-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217546/
https://www.ncbi.nlm.nih.gov/pubmed/28057014
http://dx.doi.org/10.1186/s13045-016-0378-7

Ejemplares similares